In my childhood, productivity meant going to school, doing homework, getting some playtime in, and ending the day, only to restart the cycle the next day. As I grew older, productivity took on new meaning. It meant checking every box on my to-do list: excelling at work, keeping up with…
Obexelimab, Zenas Biopharma’s experimental, self-administered injectable therapy, reduced the risk of disease flares in adults with immunoglobulin G4-related disease (IgG4-RD), according to new Phase 3 trial results. The findings come from top-line results presented by the company from the global Phase 3 INDIGO clinical trial (NCT05662241), which…
The risk of developing cancer is more than four times higher in people with immunoglobulin G4-related disease (IgG4-RD) compared with the general population, with the greatest risk seen during the first year after diagnosis. That’s according to a large-scale nationwide study from South Korea. The researchers also found that…
Get regular updates to your inbox.
